다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

ACONW

Aclarion (ACONW)

Aclarion Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACONW

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	04:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACONW	Aclarion Inc
2024/04/25	22:14	GlobeNewswire Inc.	Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
2024/03/04	22:00	GlobeNewswire Inc.	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	NASDAQ:ACONW	Aclarion Inc
2024/02/28	05:22	GlobeNewswire Inc.	Aclarion Announces Closing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
2024/02/26	23:15	GlobeNewswire Inc.	Aclarion Announces Pricing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
2024/02/05	22:00	GlobeNewswire Inc.	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	NASDAQ:ACONW	Aclarion Inc
2024/01/22	22:00	GlobeNewswire Inc.	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	NASDAQ:ACONW	Aclarion Inc
2024/01/17	22:00	GlobeNewswire Inc.	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	NASDAQ:ACONW	Aclarion Inc
2024/01/08	22:00	GlobeNewswire Inc.	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
2024/01/03	02:00	GlobeNewswire Inc.	Aclarion Announces Reverse Stock Split	NASDAQ:ACONW	Aclarion Inc
2023/11/27	22:00	GlobeNewswire Inc.	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	NASDAQ:ACONW	Aclarion Inc
2023/11/08	22:00	GlobeNewswire Inc.	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption	NASDAQ:ACONW	Aclarion Inc
2023/11/06	22:00	GlobeNewswire Inc.	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD	NASDAQ:ACONW	Aclarion Inc
2023/11/01	21:00	GlobeNewswire Inc.	Aclarion Presents at the NIH HEAL Initiative Fall Meeting	NASDAQ:ACONW	Aclarion Inc
2023/10/25	21:30	GlobeNewswire Inc.	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver	NASDAQ:ACONW	Aclarion Inc
2023/10/24	21:45	GlobeNewswire Inc.	Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting	NASDAQ:ACONW	Aclarion Inc
2023/10/23	20:00	GlobeNewswire Inc.	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
2023/10/02	21:00	GlobeNewswire Inc.	Aclarion Provides Updated Investor Presentation and Corporate Update	NASDAQ:ACONW	Aclarion Inc
2023/08/26	05:10	GlobeNewswire Inc.	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report	NASDAQ:ACONW	Aclarion Inc
2023/06/15	00:27	GlobeNewswire Inc.	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI	NASDAQ:ACONW	Aclarion Inc
2023/06/08	20:30	GlobeNewswire Inc.	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting	NASDAQ:ACONW	Aclarion Inc
2023/05/30	20:30	GlobeNewswire Inc.	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic	NASDAQ:ACONW	Aclarion Inc
2023/05/23	20:30	GlobeNewswire Inc.	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD	NASDAQ:ACONW	Aclarion Inc
2023/05/23	20:00	GlobeNewswire Inc.	Aclarion, Inc. Announces Delayed 10-Q Filing	NASDAQ:ACONW	Aclarion Inc
2023/05/19	20:30	GlobeNewswire Inc.	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts	NASDAQ:ACONW	Aclarion Inc
2023/05/02	20:00	GlobeNewswire Inc.	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
2023/04/29	00:20	GlobeNewswire Inc.	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023	NASDAQ:ACONW	Aclarion Inc
2023/04/24	20:00	GlobeNewswire Inc.	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial	NASDAQ:ACONW	Aclarion Inc
2023/03/07	23:19	GlobeNewswire Inc.	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor	NASDAQ:ACONW	Aclarion Inc
2023/02/15	21:00	GlobeNewswire Inc.	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium	NASDAQ:ACONW	Aclarion Inc

검색 관련기사 보기:NASDAQ:ACONW

Bnp Paribas Floating Rat...

Auscan Resources (CE)

Societe Generale Effekten

Adler Real Estate

BNP Paribas Issuance

Banque Postale Home Loan...

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관